Varex Imaging Corporation (VREX)
NASDAQ: VREX · Real-Time Price · USD
18.49
+0.02 (0.08%)
Sep 3, 2026, 12:15 PM EDT - Market open
Varex Imaging Revenue
Varex Imaging had revenue of $210.50M in the quarter ending July 3, 2026, with 3.69% growth. This brings the company's revenue in the last twelve months to $865.00M, up 1.08% year-over-year. In the fiscal year ending October 3, 2025, Varex Imaging had annual revenue of $844.60M with 4.14% growth.
Revenue (ttm)
$865.00M
Revenue Growth
+1.08%
P/S Ratio
0.90
Revenue / Employee
$346,000
Employees
2,500
Market Cap
779.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 3, 2025 | 844.60M | 33.60M | 4.14% |
| Sep 27, 2024 | 811.00M | -82.40M | -9.22% |
| Sep 29, 2023 | 893.40M | 34.00M | 3.96% |
| Sep 30, 2022 | 859.40M | 41.30M | 5.05% |
| Oct 1, 2021 | 818.10M | 79.80M | 10.81% |
| Oct 2, 2020 | 738.30M | -42.30M | -5.42% |
| Sep 27, 2019 | 780.60M | 7.20M | 0.93% |
| Sep 28, 2018 | 773.40M | 75.30M | 10.79% |
| Sep 29, 2017 | 698.10M | 78.00M | 12.58% |
| Sep 30, 2016 | 620.10M | -12.20M | -1.93% |
| Sep 30, 2015 | 632.30M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.36B |
| QuidelOrtho | 2.67B |
| InMode | 374.63M |
| OrthoPediatrics | 252.72M |
| SI-BONE | 213.60M |
| Cytek Biosciences | 206.71M |
| Beta Bionics | 119.01M |
| CeriBell | 101.96M |
VREX News
- 6 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Varex Imaging Corporation (Nasdaq – VREX), Synlogic, Inc. (OTC – SYBX), Bowman Consulting Group Ltd. (Nasdaq – BWMN), Nathan's Famous, Inc. (Nasdaq – NATH) - GlobeNewsWire
- 17 days ago - Varex Imaging downgraded to Market Perform from Outperform at CJS Securities - TheFly
- 22 days ago - Varex Imaging Proxy statement: Proxy filing - Filings
- 23 days ago - Varex Imaging downgraded to Perform from Outperform at Oppenheimer - TheFly
- 23 days ago - Varex Imaging Earnings release: Q3 2026 - Filings
- 23 days ago - Varex Imaging Quarterly report: Q3 2026 - Filings
- 24 days ago - Varex Imaging downgraded to Neutral from Buy at B. Riley - TheFly
- 24 days ago - Varex Imaging downgraded to Neutral from Buy at Sidoti - TheFly